Amniotic Biomarkers for the Prediction of Postpartum Renal Function.

INCLUSION CRITERIA: All fetuses with a bilateral abnormal renal development (structure modification of the parenchyma with or without urinary tract abnormalities associated) The following sonographic criteria are used: * Fetal kidney size \<2.5ep or \<2 standard deviation (SD) defining renal hypoplasia or renal size\> 97.5ep or\> 2 SD defining nephromegaly * And / or hyperechogenicity (more echogenic than the liver kidney) * And / or cysts * And / or abnormal cortico-medullary differentiation (decrease or lack thereof) * And / or bilateral cortical thinning * And / or the possibility of an initial unilateral renal disease in the case of a pathology on which kidney damage is usually to become bilateral during evolution EXCLUSION CRITERIA: * Foetuses with severe malformations that can change the amniotic or urine proteome: complex heart disease, digestive stenosis, fetal immobility. * Fetus whose mother has chronic infectious diseases (HIV, hepatitis B and C) or acute infectious diseases such chorioamnionitis. * Parental Refusal.